{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:57:49Z","timestamp":1792742269066,"version":"4.5.0"},"reference-count":260,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.wneu.2019.03.049","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T03:23:15Z","timestamp":1561778595000},"page":"695-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Pituitary Adenomas: What Are the Key Features? What Are the Current Treatments? Where Is the Future Taking Us?"],"prefix":"10.1016","volume":"127","author":[{"given":"Domenico","family":"Solari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Caggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Guadagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Chiaramonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Miccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi M.","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialaura","family":"Del Basso De Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cappabianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2019.03.049_bib1","first-page":"527","article-title":"Descriptive epidemiology of pituitary tumors in the United States, 2004-2009","volume":"121","author":"Gittleman","year":"2014","journal-title":"J\u00a0Neurosurg"},{"issue":"suppl 2","key":"10.1016\/j.wneu.2019.03.049_bib2","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/neuonc\/not151","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010","volume":"15","author":"Ostrom","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2019.03.049_bib3","series-title":"Brain Tumors","first-page":"804","article-title":"Pituitary tumors","author":"Thapar","year":"2001"},{"key":"10.1016\/j.wneu.2019.03.049_bib4","first-page":"429","article-title":"Endonasal endoscopic pituitary surgery in the elderly","volume":"128","author":"Wilson","year":"2018","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/B978-0-444-59602-4.00019-8","article-title":"Surgical approach to pituitary tumors","volume":"124","author":"Solari","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.wneu.2019.03.049_bib6","first-page":"306","article-title":"Pituitary tumors\u2013long-term outcomes and expectations","volume":"48","author":"Laws","year":"2001","journal-title":"Clin Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00701-015-2699-7","article-title":"Assessing size of pituitary adenomas: a comparison of qualitative and quantitative methods on MR","volume":"158","author":"Davies","year":"2016","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2019.03.049_bib8","first-page":"75","article-title":"Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection","volume":"121","author":"Juraschka","year":"2014","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib9","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00701-014-2213-7","article-title":"Size does not matter. The intrigue of giant adenomas: a true surgical challenge","volume":"156","author":"Cappabianca","year":"2014","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2019.03.049_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nec.2015.03.007","article-title":"Endoscopic endonasal extended approaches for the management of large pituitary adenomas","volume":"26","author":"Cappabianca","year":"2015","journal-title":"Neurosurg Clin North Am"},{"key":"10.1016\/j.wneu.2019.03.049_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-07-0348","article-title":"The clinical, pathological, and genetic features of familial isolated pituitary adenomas","volume":"157","author":"Beckers","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2796.2009.02109.x","article-title":"Familial pituitary adenomas","volume":"266","author":"Tichomirowa","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.wneu.2019.03.049_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.beem.2010.03.001","article-title":"The genetics of pituitary adenomas","volume":"24","author":"Vandeva","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib14","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/jc.2007-2611","article-title":"The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas","volume":"93","author":"Leontiou","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/B978-0-444-59602-4.00023-X","article-title":"Familial pituitary tumors","volume":"124","author":"Alband","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.wneu.2019.03.049_bib16","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1172\/JCI11887","article-title":"Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly","volume":"107","author":"Hayward","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.wneu.2019.03.049_bib17","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1210\/jc.2011-1179","article-title":"Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?","volume":"97","author":"Xekouki","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.endonu.2012.02.009","article-title":"Coexistence of a pituitary macroadenoma and multicentric paraganglioma: a strange coincidence","volume":"60","author":"Varsavsky","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.wneu.2019.03.049_bib19","first-page":"14","article-title":"Pituitary adenoma","volume":"Vol 10","author":"Osamura","year":"2017"},{"key":"10.1016\/j.wneu.2019.03.049_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","article-title":"The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas","volume":"26","author":"Nishioka","year":"2015","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.wneu.2019.03.049_bib21","series-title":"Pathology and Genetics of Tumours of Endocrine Organs","first-page":"9","article-title":"Tumours of the pituitary gland","author":"Lloyd","year":"2004"},{"key":"10.1016\/j.wneu.2019.03.049_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A\u00a0new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2019.03.049_bib23","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1172\/JCI39375","article-title":"Acromegaly pathogenesis and treatment","volume":"119","author":"Melmed","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.wneu.2019.03.049_bib24","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1056\/NEJM199004053221405","article-title":"Acromegaly","volume":"322","author":"Melmed","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2019.03.049_bib25","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","article-title":"Guidelines for acromegaly management: an update","volume":"94","author":"Melmed","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0889-8529(18)30204-4","article-title":"Clinical manifestations of acromegaly","volume":"21","author":"Molitch","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.wneu.2019.03.049_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1987.tb00805.x","article-title":"Acromegaly","volume":"26","author":"Nabarro","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.wneu.2019.03.049_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11102-017-0797-7","article-title":"Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities","volume":"20","author":"Pivonello","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00024677-200403050-00004","article-title":"Cardiac abnormalities in acromegaly. Pathophysiology and implications for management","volume":"3","author":"Vitale","year":"2004","journal-title":"Treat Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib31","first-page":"77","article-title":"Cardiovascular complications in acromegaly","volume":"29","author":"Vitale","year":"2004","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/jc.2003-030849","article-title":"Increased prevalence of regurgitant valvular heart disease in acromegaly","volume":"89","author":"Pereira","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib33","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.wneu.2019.03.049_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/jc.2004-0240","article-title":"Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy","volume":"90","author":"Terzolo","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib36","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1210\/jcem.86.7.7635","article-title":"Acromegaly and cancer: not a problem?","volume":"86","author":"Melmed","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib37","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1210\/jcem.85.9.6775","article-title":"The prevalence and characteristics of colorectal neoplasia in acromegaly","volume":"85","author":"Renehan","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2265.2001.01418.x","article-title":"Colorectal neoplasia in acromegaly","volume":"55","author":"Jenkins","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0960-0760(92)90077-V","article-title":"Glucocorticoid-dependent hypertension","volume":"43","author":"Mantero","year":"1992","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.wneu.2019.03.049_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.HYP.23.1.25","article-title":"Glucocorticoid increases angiotensin II type 1 receptor and its gene expression","volume":"23","author":"Sato","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.wneu.2019.03.049_bib41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ajh\/6.4.287","article-title":"Hydrocortisone-induced hypertension in men. The role of cardiac output","volume":"6","author":"Pirpiris","year":"1993","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.wneu.2019.03.049_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-2265.1999.00766.x","article-title":"Increased pressor response to noradrenaline in pituitary dependent Cushing's syndrome","volume":"51","author":"Heaney","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib43","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1210\/jc.2003-030254","article-title":"Occult Cushing's syndrome in type-2 diabetes","volume":"88","author":"Catargi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib44","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/sleep\/15.6.514","article-title":"Sleep architecture and sleep apnea in patients with Cushing's disease","volume":"15","author":"Shipley","year":"1992","journal-title":"Sleep"},{"key":"10.1016\/j.wneu.2019.03.049_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/eje.0.1490561","article-title":"Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"suppl 1","key":"10.1016\/j.wneu.2019.03.049_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000314317","article-title":"Neuropsychiatric disorders in Cushing's syndrome","volume":"92","author":"Pereira","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.wneu.2019.03.049_bib47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ando.2016.04.001","article-title":"Prolactinoma and pregnancy: from the wish of conception to lactation","volume":"77","author":"Maiter","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.wneu.2019.03.049_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12020-017-1438-7","article-title":"Prolactinoma through the female life cycle","volume":"59","author":"Cocks Eschler","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.wneu.2019.03.049_bib49","first-page":"1073","article-title":"Evaluation and management of galactorrhea","volume":"85","author":"Huang","year":"2012","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.wneu.2019.03.049_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12020-016-0863-3","article-title":"Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management","volume":"52","author":"Amlashi","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.wneu.2019.03.049_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11102-017-0855-1","article-title":"Histopathological classification of non-functioning pituitary neuroendocrine tumors","volume":"21","author":"Manojlovic-Gacic","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib52","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1530\/eje.1.02030","article-title":"Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature","volume":"153","author":"Minniti","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1227\/NEU.0000000000000563","article-title":"Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas","volume":"76","author":"Dallapiazza","year":"2015","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11060-010-0302-x","article-title":"A\u00a0prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome","volume":"102","author":"Chen","year":"2011","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2019.03.049_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2017.03.023","article-title":"Non-functioning pituitary adenoma underwent surgery: a multicenter retrospective study over the last four decades (1977-2015)","volume":"41","author":"Iglesias","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.wneu.2019.03.049_bib56","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1227\/NEU.0000000000001067","article-title":"Headache in patients with pituitary lesions: a longitudinal cohort study","volume":"78","author":"Rizzoli","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib57","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1210\/jc.2012-4171","article-title":"Pituitary stalk lesions: the Mayo Clinic experience","volume":"98","author":"Turcu","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib58","first-page":"241","article-title":"Diagnosis and treatment of pituitary adenomas","volume":"29","author":"Chanson","year":"2004","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/014107688607900504","article-title":"Transsphenoidal surgery for Cushing's disease","volume":"79","author":"Fahlbusch","year":"1986","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.wneu.2019.03.049_bib60","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1227\/01.NEU.0000215945.26764.92","article-title":"Surgical treatment of recurrent Cushing's disease","volume":"58","author":"Hofmann","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib61","first-page":"948","article-title":"Cushing disease","volume":"98","author":"Oldfeld","year":"2003","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib62","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.wneu.2012.07.034","article-title":"Early morning cortisol levels as predictors of short and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts","volume":"80","author":"McLaughlin","year":"2013","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib63","first-page":"520","article-title":"Repeat transsphenoidal surgery for Cushing's disease","volume":"71","author":"Friedman","year":"1989","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib64","first-page":"3114","article-title":"Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group","volume":"80","author":"Bochicchio","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0303-7207(02)00281-2","article-title":"The neurosurgical management of Cushing's disease","volume":"197","author":"Reitmeyer","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib66","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/foc.2007.23.3.7","article-title":"Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome","volume":"23","author":"Kelly","year":"2007","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2019.03.049_bib67","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib68","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing's disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.wneu.2019.03.049_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ecl.2014.10.006","article-title":"Medical treatment of Cushing disease: new targets, new hope","volume":"44","author":"Fleseriu","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.wneu.2019.03.049_bib71","doi-asserted-by":"crossref","first-page":"746","DOI":"10.4158\/EP14147.RA","article-title":"AACE\/ACE Disease State Clinical Review: medical management of Cushing disease","volume":"20","author":"Hamrahian","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.wneu.2019.03.049_bib72","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/14728214.2015.1047762","article-title":"Emerging drugs for Cushing's disease","volume":"20","author":"Guelho","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.wneu.2019.03.049_bib73","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrendo.2010.233","article-title":"Pituitary tumors in 2010: a new therapeutic era for pituitary tumors","volume":"7","author":"Gueorguiev","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib74","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000318507","article-title":"Medical therapy of Cushing's disease: where are we now?","volume":"38","author":"Alexandraki","year":"2010","journal-title":"Front Horm Res"},{"key":"10.1016\/j.wneu.2019.03.049_bib75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11102-009-0209-8","article-title":"Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease","volume":"13","author":"Vilar","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib77","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11102-013-0475-3","article-title":"Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?","volume":"17","author":"Barbot","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib78","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4158\/EP10031.OR","article-title":"Efficacy of cabergoline in uncured (persistent or recurrent) Cushing disease after pituitary surgical treatment with or without radiotherapy","volume":"16","author":"Lila","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/j.wneu.2019.03.049_bib79","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/EJE-10-0382","article-title":"Cabergoline monotherapy in the long-term treatment of Cushing's disease","volume":"163","author":"Godbout","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2008-1008","article-title":"Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial","volume":"94","author":"Boscaro","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib81","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A\u00a012-month phase 3 study of pasireotide in Cushing's disease","volume":"366","author":"Colao","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2019.03.049_bib82","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s11102-014-0618-1","article-title":"Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial","volume":"18","author":"Schopohl","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib83","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1055\/s-0042-101347","article-title":"A\u00a0single-center 10-year experience with pasireotide in Cushing's disease: patients' characteristics and outcome","volume":"48","author":"Trementino","year":"2016","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.wneu.2019.03.049_bib84","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12020-017-1316-3","article-title":"Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a phase III trial","volume":"57","author":"Petersenn","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.wneu.2019.03.049_bib85","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cen.12431","article-title":"Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a phase III study","volume":"81","author":"Pivonello","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib86","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12020-015-0557-2","article-title":"The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center","volume":"50","author":"Simeoli","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.wneu.2019.03.049_bib87","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11102-013-0483-3","article-title":"Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations","volume":"17","author":"Colao","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib88","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1172\/JCI110903","article-title":"Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes","volume":"71","author":"Loose","year":"1983","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.wneu.2019.03.049_bib89","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1210\/edrv-7-4-409","article-title":"Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis","volume":"7","author":"Feldman","year":"1986","journal-title":"Endocr Rev"},{"key":"10.1016\/j.wneu.2019.03.049_bib90","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM198709243171307","article-title":"The use of ketoconazole as an inhibitor of steroid production","volume":"317","author":"Sonino","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.wneu.2019.03.049_bib91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000314292","article-title":"Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole","volume":"92","author":"Feelders","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.wneu.2019.03.049_bib92","first-page":"185","article-title":"In\u00a0vitro effects of ketoconazole on corticotrope cell morphology and ACTH secretion of two pituitary adenomas removed from patients with Nelson's syndrome","volume":"121","author":"Jimenez Reina","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.wneu.2019.03.049_bib93","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2265.1991.tb03547.x","article-title":"Ketoconazole treatment in Cushing's syndrome: experience in 34 patients","volume":"35","author":"Sonino","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib94","first-page":"26","article-title":"Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing's syndrome","volume":"67","author":"Moncet","year":"2007","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.wneu.2019.03.049_bib95","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-07-0514","article-title":"Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease","volume":"158","author":"Castinetti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib96","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/cen.12286","article-title":"Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease","volume":"80","author":"van den Bosch OF","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib97","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing's disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib98","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/phar.1202","article-title":"Mifepristone for management of Cushing's syndrome","volume":"33","author":"Morgan","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.wneu.2019.03.049_bib99","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0010-7824(03)00171-9","article-title":"Pharmacological properties of mifepristone: toxicology and safety in animal and human studies","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.wneu.2019.03.049_bib100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-09-0098","article-title":"Merits and pitfalls of mifepristone in Cushing's syndrome","volume":"160","author":"Castinetti","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib101","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib102","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2011-0536","article-title":"Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome","volume":"96","author":"Kamenicky","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib103","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMc1000094","article-title":"Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease","volume":"362","author":"Feelders","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2019.03.049_bib104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11154-007-9061-1","article-title":"Management of acromegaly: is there a role for primary medical therapy?","volume":"9","author":"Bush","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.wneu.2019.03.049_bib105","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/BF03349217","article-title":"First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly Primary Medical Treatment Learning and Improvement with Continuous Medical Education) study group","volume":"29","author":"Colao","year":"2006","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.wneu.2019.03.049_bib106","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1530\/eje.0.1460707","article-title":"SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile","volume":"146","author":"Bruns","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib107","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/jc.2013-2480","article-title":"Pasireotide versus octreotide in acromegaly: a head-to-head superiority study","volume":"99","author":"Colao","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib108","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2213-8587(14)70169-X","article-title":"Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial","volume":"2","author":"Gadelha","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib109","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12902-016-0096-8","article-title":"Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study","volume":"16","author":"Bronstein","year":"2016","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.wneu.2019.03.049_bib110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrendo.2014.21","article-title":"Expert consensus document: a consensus on the medical treatment of acromegaly","volume":"10","author":"Giustina","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib111","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11102-015-0684-z","article-title":"Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly","volume":"19","author":"Colao","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib112","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/er.2010-0002","article-title":"Resistance to somatostatin analogs in acromegaly","volume":"32","author":"Colao","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.wneu.2019.03.049_bib113","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3803\/EnM.2017.32.2.162","article-title":"Recent progress in the medical therapy of pituitary tumors","volume":"32","author":"Langlois","year":"2017","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib114","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib115","series-title":"Prolactin, Basic and Clinical Correlates","first-page":"849","article-title":"The role of surgery in the management of prolactinomas","author":"Laws","year":"1985"},{"key":"10.1016\/j.wneu.2019.03.049_bib116","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.wneu.2019.03.049_bib117","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/BF03349214","article-title":"Cerebrospinal fluid leakage as complication of treatment with cabergoline for macroprolactinomas","volume":"29","author":"Netea-Maier","year":"2006","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.wneu.2019.03.049_bib118","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2019.03.049_bib119","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.wneu.2016.10.059","article-title":"Long-term follow-up of primary medical versus surgical treatment of prolactinomas in men: effects on hyperprolactinemia, hypogonadism, and bone health","volume":"97","author":"Andereggen","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib120","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1210\/jcem-60-4-698","article-title":"Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study","volume":"60","author":"Molitch","year":"1985","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib121","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/edrv-13-2-220","article-title":"Dopamine agonists and pituitary tumor shrinkage","volume":"13","author":"Bevan","year":"1992","journal-title":"Endocr Rev"},{"key":"10.1016\/j.wneu.2019.03.049_bib122","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib123","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.beem.2009.05.003","article-title":"Pituitary tumours: the prolactinoma","volume":"23","author":"Colao","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib124","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem.82.3.3822","article-title":"Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment","volume":"82","author":"Colao","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2265.1997.1300952.x","article-title":"Treatment of macroprolactinoma with cabergoline: a study of 85 patients","volume":"46","author":"Ferrari","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib126","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jcem.84.7.5810","article-title":"Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients","volume":"84","author":"Verhelst","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib127","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A\u00a0comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group","volume":"331","author":"Webster","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2019.03.049_bib128","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220971","article-title":"Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective","volume":"2017","author":"Mohan","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.wneu.2019.03.049_bib129","article-title":"Beneficial effects of high doses of cabergoline in the treatment of giant prolactinoma resistant to dopamine agonists: a case report with a 21-year follow-up","author":"de Castro","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.wneu.2019.03.049_bib130","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa022657","article-title":"Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia","volume":"349","author":"Colao","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2019.03.049_bib131","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2265.2007.02905.x","article-title":"Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy","volume":"67","author":"Colao","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib132","series-title":"Endotext","article-title":"Surgical treatment of pituitary adenomas","author":"Jane","year":"2000"},{"key":"10.1016\/j.wneu.2019.03.049_bib133","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary apoplexy","volume":"36","author":"Briet","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.wneu.2019.03.049_bib134","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ecl.2014.10.016","article-title":"Pituitary apoplexy","volume":"44","author":"Briet","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.wneu.2019.03.049_bib135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/neuros\/nyx073","article-title":"Preoperative stratification of transsphenoidal pituitary surgery patients based on surgical urgency","volume":"81","author":"Zaidi","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib136","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10143-016-0740-9","article-title":"Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients","volume":"40","author":"Del Basso De Caro","year":"2017","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.wneu.2019.03.049_bib137","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1210\/jc.2014-4350","article-title":"Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide","volume":"100","author":"Bengtsson","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib138","doi-asserted-by":"crossref","first-page":"966","DOI":"10.2176\/nmc.ra.2014-0178","article-title":"Treatment of pituitary carcinomas and atypical pituitary adenomas: a review","volume":"54","author":"Hirohata","year":"2014","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2019.03.049_bib139","first-page":"188","article-title":"Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reports","volume":"3","author":"Ji","year":"2016","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.wneu.2019.03.049_bib140","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-2265.2012.04373.x","article-title":"Temozolomide in the management of dopamine agonist-resistant prolactinomas","volume":"76","author":"Whitelaw","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib141","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11060-014-1702-0","article-title":"Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center","volume":"122","author":"Ceccato","year":"2015","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2019.03.049_bib142","first-page":"303","article-title":"Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes","volume":"114","author":"Sheehan","year":"2011","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib143","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1530\/EJE-13-0400","article-title":"Gamma Knife surgery for patients with volumetric classification of nonfunctioning pituitary adenomas: a systematic review and meta-analysis","volume":"169","author":"Chen","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib144","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clineuro.2016.09.009","article-title":"Fractionated Gamma Knife surgery for giant pituitary adenomas","volume":"150","author":"Zhao","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10143-007-0072-x","article-title":"Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques","volume":"30","author":"Minniti","year":"2007","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.wneu.2019.03.049_bib146","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1227\/NEU.0b013e31826d5d06","article-title":"Pituitary centers of excellence","volume":"71","author":"McLaughlin","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib147","series-title":"Endoscopic Endonasal Transsphenoidal Surgery","first-page":"9","article-title":"The endoscope, endoscopic equipment and instrumentation","author":"Leonhard","year":"2003"},{"key":"10.1016\/j.wneu.2019.03.049_bib148","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/foc.2005.19.6.4","article-title":"Brief history of endoscopic transsphenoidal surgery\u2013from Philipp Bozzini to the First World Congress of Endoscopic Skull Base Surgery","volume":"19","author":"Doglietto","year":"2005","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2019.03.049_bib149","series-title":"Keyhole Concept in Neurosurgery","author":"Perneczky","year":"1999"},{"key":"10.1016\/j.wneu.2019.03.049_bib150","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.3171\/foc.2005.18.4.7","article-title":"The transsphenoidal approach. A historical perspective","volume":"18","author":"Kanter","year":"2005","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2019.03.049_bib151","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1227\/01.NEU.0000119325.14116.9C","article-title":"Endoscopy and transsphenoidal surgery","volume":"54","author":"Cappabianca","year":"2004","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib152","series-title":"Endocrinology","first-page":"358","article-title":"Pituitary surgery","author":"Cappabianca","year":"2010"},{"key":"10.1016\/j.wneu.2019.03.049_bib153","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/00005537-199607000-00025","article-title":"Transnasal-transsphenoidal endoscopic surgery of the pituitary gland","volume":"106","author":"Carrau","year":"1996","journal-title":"Laryngoscope"},{"key":"10.1016\/j.wneu.2019.03.049_bib154","first-page":"1","article-title":"Endoscopic pituitary surgery","volume":"Vol 5","author":"Jho","year":"1996"},{"key":"10.1016\/j.wneu.2019.03.049_bib155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2008-1052019","article-title":"Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS)","volume":"41","author":"Cappabianca","year":"1998","journal-title":"Minim Invasive Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib156","series-title":"Endoscopic Endonasal Transsphenoidal Surgery","first-page":"91","article-title":"Endoscopic endonasal transsphenoidal approach to the sellar region","author":"de Divitiis","year":"2003"},{"key":"10.1016\/j.wneu.2019.03.049_bib157","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1227\/01.NEU.0000137330.02549.0D","article-title":"Endoscopic endonasal transsphenoidal surgery","volume":"55","author":"Cappabianca","year":"2004","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib158","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2500\/105065899782102827","article-title":"Endoscopically assisted anterior cranial skull base resection of sinonasal tumors","volume":"13","author":"Thaler","year":"1999","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib159","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0090-3019(99)00195-0","article-title":"Endoscopic-guided direct endonasal approach for pituitary surgery","volume":"53","author":"Badie","year":"2000","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2019.03.049_bib160","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0030-6665(05)70371-6","article-title":"Pituitary surgery","volume":"34","author":"Carrau","year":"2001","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.wneu.2019.03.049_bib161","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1179\/016164101101198280","article-title":"Approaches to the sellar and parasellar region: anatomic comparison of endonasal-transsphenoidal, sublabial-transsphenoidal, and transethmoidal approaches","volume":"23","author":"Das","year":"2001","journal-title":"Neurol Res"},{"key":"10.1016\/j.wneu.2019.03.049_bib162","first-page":"1083","article-title":"The history and evolution of transsphenoidal surgery","volume":"95","author":"Liu","year":"2001","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib163","first-page":"357","article-title":"Transsphenoidal surgery","volume":"Vol 1","author":"Laws","year":"1993"},{"key":"10.1016\/j.wneu.2019.03.049_bib164","series-title":"Transsphenoidal Surgery","year":"2010"},{"key":"10.1016\/j.wneu.2019.03.049_bib165","first-page":"200","article-title":"Transcranial surgery for large pituitary adenomas","volume":"Vol. IV B","author":"Yasargil","year":"1996"},{"key":"10.1016\/j.wneu.2019.03.049_bib166","first-page":"215","article-title":"General operative techniques","volume":"Vol. I","author":"Yasargil","year":"1984"},{"key":"10.1016\/j.wneu.2019.03.049_bib167","series-title":"Schmideck & Sweet Operative Neurosurgical Technique. Indications, Methods and Results","first-page":"373","article-title":"Transsphenoidal approach to lesion of the sella","author":"Elias","year":"2000"},{"issue":"6 suppl","key":"10.1016\/j.wneu.2019.03.049_bib168","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.wneu.2014.07.019","article-title":"Endoscopic endonasal surgery for pituitary adenomas","volume":"82","author":"Cappabianca","year":"2014","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib169","first-page":"345","article-title":"Extended endoscopic endonasal approach for selected pituitary adenomas: early experience","volume":"114","author":"Di Maio","year":"2011","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib170","series-title":"Schmidek & Sweet Operative Neurosurgical Techniques","first-page":"385","article-title":"Endoscopic transsphenoidal surgery","author":"Jho","year":"2000"},{"key":"10.1016\/j.wneu.2019.03.049_bib171","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11102-008-0087-5","article-title":"Endoscopic pituitary surgery","volume":"11","author":"Cappabianca","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib172","first-page":"137","article-title":"Endoscopic endonasal transsphenoidal surgery","volume":"Vol 27","author":"de Divitiis","year":"2002"},{"key":"10.1016\/j.wneu.2019.03.049_bib173","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MED.0b013e32833abcba","article-title":"The role of outcomes data for assessing the expertise of a pituitary surgeon","volume":"17","author":"Shahlaie","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.wneu.2019.03.049_bib174","first-page":"2","article-title":"Different surgical approaches to the sellar region: focusing on the \"two nostrils four hands technique\"","volume":"44","author":"Castelnuovo","year":"2006","journal-title":"Rhinology"},{"key":"10.1016\/j.wneu.2019.03.049_bib175","first-page":"7","article-title":"Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors","volume":"104","author":"Oldfield","year":"2006","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib176","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1227\/01.NEU.0000249211.89096.25","article-title":"Extended endoscopic endonasal transsphenoidal approach for the removal of suprasellar tumors: Part 2","volume":"60","author":"de Divitiis","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib177","first-page":"E3","article-title":"Expanded endonasal approach: the rostrocaudal axis. Part I. Crista galli to the sella turcica","volume":"19","author":"Kassam","year":"2005","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2019.03.049_bib178","series-title":"Advances and Technical Standards in Neurosurgery","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/978-3-211-72283-1_4","article-title":"Extended endoscopic endonasal approach to the midline skull base: the evolving role of transsphenoidal surgery","author":"Cappabianca","year":"2008"},{"key":"10.1016\/j.wneu.2019.03.049_bib179","first-page":"E2","article-title":"Endoscopic endonasal surgery of the midline skull base: anatomical study and clinical considerations","volume":"19","author":"Cavallo","year":"2005","journal-title":"Neurosurg Focus"},{"issue":"2 suppl","key":"10.1016\/j.wneu.2019.03.049_bib180","first-page":"ONS379","article-title":"Endoscopic transnasal approach to the cavernous sinus versus transcranial route: anatomic study","volume":"56","author":"Cavallo","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib181","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1227\/00006123-200203000-00060","article-title":"Endoscopic endonasal approaches to the cavernous sinus: surgical approaches","volume":"50","author":"Frank","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib182","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/00006123-200212000-00006","article-title":"Sellar repair in endoscopic endonasal transsphenoidal surgery: results of 170 cases","volume":"51","author":"Cappabianca","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib183","first-page":"713","article-title":"Skull base reconstruction in the extended endoscopic transsphenoidal approach for suprasellar lesions","volume":"107","author":"Cavallo","year":"2007","journal-title":"J\u00a0Neurosurg"},{"issue":"4 suppl 2","key":"10.1016\/j.wneu.2019.03.049_bib184","first-page":"295","article-title":"Graded repair of cranial base defects and cerebrospinal fluid leaks in transsphenoidal surgery","volume":"60","author":"Esposito","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib185","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2265.2005.02231.x","article-title":"Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up","volume":"62","author":"Karavitaki","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib186","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000368401","article-title":"Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndrome","volume":"82","author":"Gonzalez Briceno","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.wneu.2019.03.049_bib187","first-page":"572","article-title":"Adult craniopharyngiomas: surgical results with a special focus on endocrinological outcomes and recurrence according to pituitary stalk preservation","volume":"111","author":"Jung","year":"2009","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib188","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clineuro.2015.05.019","article-title":"Association of pituitary stalk management with endocrine outcomes and recurrence in microsurgery of craniopharyngiomas: a meta-analysis","volume":"136","author":"Li","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib189","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1210\/jc.2011-3237","article-title":"Update on pituitary surgery","volume":"97","author":"Swearingen","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib190","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF03350330","article-title":"Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas","volume":"21","author":"Colao","year":"1998","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.wneu.2019.03.049_bib191","first-page":"438","article-title":"Gamma Knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking","volume":"100","author":"Losa","year":"2004","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib192","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2265.2005.02199.x","article-title":"The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas","volume":"62","author":"Minniti","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib193","first-page":"678","article-title":"Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium","volume":"102","author":"Sheehan","year":"2005","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib194","first-page":"736","article-title":"Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas","volume":"108","author":"Chang","year":"2008","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib195","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2265.2009.03665.x","article-title":"Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas","volume":"72","author":"de Paiva Neto","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2019.03.049_bib196","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11060-007-9344-0","article-title":"Long-term follow-up results of postoperative radiation therapy for Cushing's disease","volume":"84","author":"Minniti","year":"2007","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2019.03.049_bib197","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00066-014-0802-2","article-title":"Treatment of acromegaly patients with risk-adapted single or fractionated stereotactic high-precision radiotherapy: high local control and low toxicity in a pooled series","volume":"191","author":"Bostr\u00f6m","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.wneu.2019.03.049_bib198","doi-asserted-by":"crossref","first-page":"E539","DOI":"10.1227\/NEU.0000000000001385","article-title":"Congress of Neurological Surgeons systematic review and evidence-based guideline for the management of patients with residual or recurrent nonfunctioning pituitary adenomas","volume":"79","author":"Sheehan","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib199","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11102-018-0865-7","article-title":"Management of NFAs: medical treatment","volume":"21","author":"Even-Zohar","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib200","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ijrobp.2018.02.023","article-title":"Endocrine remission after pituitary stereotactic radiosurgery: differences in rates of response for matched cohorts of Cushing disease and acromegaly patients","volume":"101","author":"Trifiletti","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2019.03.049_bib201","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11102-016-0781-7","article-title":"Management of aggressive growth hormone secreting pituitary adenomas","volume":"20","author":"Donoho","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0360-3016(93)90230-S","article-title":"Tolerance of cranial nerves of the cavernous sinus to radiosurgery","volume":"27","author":"Tishler","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2019.03.049_bib203","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0360-3016(02)04380-8","article-title":"A\u00a0study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery","volume":"55","author":"Stafford","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2019.03.049_bib204","author":"Milano"},{"key":"10.1016\/j.wneu.2019.03.049_bib205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WNO.0b013e3181a57d19","article-title":"Ocular neuromyotonia after gamma knife stereotactic radiation therapy","volume":"29","author":"Much","year":"2009","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.wneu.2019.03.049_bib206","first-page":"251","article-title":"[Fractionated stereotactic irradiation of skull-base related tumours]","volume":"57","author":"Horv\u00e1th","year":"2013","journal-title":"Magy Onkol"},{"key":"10.1016\/j.wneu.2019.03.049_bib207","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13014-017-0841-9","article-title":"Radiation therapy for older patients with brain tumors","volume":"12","author":"Minniti","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.wneu.2019.03.049_bib208","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11102-016-0783-5","article-title":"Updates in outcomes of stereotactic radiation therapy in acromegaly","volume":"20","author":"Gheorghiu","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib209","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11060-014-1501-7","article-title":"Unyielding progress: recent advances in the treatment of central nervous system neoplasms with radiosurgery and radiation therapy","volume":"119","author":"Ding","year":"2014","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2019.03.049_bib210","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/era.12.27","article-title":"Radiotherapy-induced hypopituitarism: a review","volume":"12","author":"Sathyapalan","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.wneu.2019.03.049_bib211","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-717X-6-36","article-title":"Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.wneu.2019.03.049_bib212","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.rpor.2016.06.002","article-title":"Outcome of radiotherapy for pituitary adenomas","volume":"21","author":"Sebastian","year":"2016","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.wneu.2019.03.049_bib213","doi-asserted-by":"crossref","first-page":"E533","DOI":"10.1227\/NEU.0000000000001389","article-title":"Congress of Neurological Surgeons systematic review and evidence-based guideline on primary management of patients with nonfunctioning pituitary adenomas","volume":"79","author":"Lucas","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib214","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11102-018-0868-4","article-title":"Management of nonfunctioning pituitary tumors: radiotherapy","volume":"21","author":"Minniti","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib215","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.radonc.2016.10.014","article-title":"Assessment of organs-at-risk contouring practices in radiosurgery institutions around the world\u2013the first initiative of the OAR Standardization Working Group","volume":"121","author":"Sandstr\u00f6m","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.wneu.2019.03.049_bib216","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-017-2370-7","article-title":"Clinical efficacy and safety of surface imaging guided radiosurgery (SIG-RS) in the treatment of benign skull base tumors","volume":"132","author":"Lau","year":"2017","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2019.03.049_bib217","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jocn.2013.04.007","article-title":"Cushing's disease: a single centre's experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy","volume":"21","author":"Wilson","year":"2014","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2019.03.049_bib218","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11060-017-2520-y","article-title":"Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study","volume":"135","author":"Cohen-Inbar","year":"2017","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2019.03.049_bib219","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2213-8587(17)30326-1","article-title":"Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial","volume":"6","author":"Lacroix","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib220","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jc.2013-2117","article-title":"LCI699, a potent 11beta-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study","volume":"99","author":"Bertagna","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib221","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11102-015-0692-z","article-title":"Osilodrostat, a potent oral 11beta-hydroxylase inhibitor: 22-week, prospective, phase II study in Cushing's disease","volume":"19","author":"Fleseriu","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2019.03.049_bib222","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/jm00093a015","article-title":"Stereoisomers of ketoconazole: preparation and biological activity","volume":"35","author":"Rotstein","year":"1992","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.wneu.2019.03.049_bib223","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1172\/JCI112662","article-title":"Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in\u00a0vivo in rat by inhibiting cholesterol 7 alpha-hydroxylase","volume":"78","author":"Princen","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.wneu.2019.03.049_bib224","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1677\/joe.1.05616","article-title":"Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells","volume":"183","author":"Theodoropoulou","year":"2004","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib225","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.wneu.2019.03.049_bib226","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1073\/pnas.1018091108","article-title":"Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.wneu.2019.03.049_bib227","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrendo.2015.196","article-title":"New therapeutic agents for acromegaly","volume":"12","author":"Melmed","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib228","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/endo.142.1.7880","article-title":"Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin","volume":"142","author":"Afargan","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.wneu.2019.03.049_bib229","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1530\/EJE-11-0737","article-title":"DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in octreotide non-responsive tumours","volume":"166","author":"Plockinger","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2019.03.049_bib230","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/BF03347512","article-title":"PTR-3173 (somatoprim), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretion","volume":"27","author":"Shimon","year":"2004","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.wneu.2019.03.049_bib231","first-page":"347","article-title":"Antisense oligonucleotides: basic concepts and mechanisms","volume":"1","author":"Dias","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.wneu.2019.03.049_bib232","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s11095-014-1303-9","article-title":"A\u00a0novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms","volume":"31","author":"Tuvia","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.wneu.2019.03.049_bib233","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1210\/jc.2014-4113","article-title":"Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial","volume":"100","author":"Melmed","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2019.03.049_bib234","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00006123-200209000-00016","article-title":"Endoscopic transsphenoidal approach: adaptability of the procedure to different sellar lesions","volume":"51","author":"de Divitiis","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib235","first-page":"24","article-title":"Extended endoscopic endonasal transsphenoidal approach to the suprasellar area: anatomic considerations\u2013part 1","volume":"61","author":"Cavallo","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib236","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1227\/01.NEU.0000339121.20101.85","article-title":"Expanded endoscopic endonasal approach for anterior cranial base and suprasellar lesions: indications and limitations","volume":"64","author":"Dehdashti","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib237","first-page":"E4","article-title":"Expanded endonasal approach: the rostrocaudal axis. Part II. Posterior clinoids to the foramen magnum","volume":"19","author":"Kassam","year":"2005","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2019.03.049_bib238","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/foc.2005.19.1.7","article-title":"Expanded endonasal approach: fully endoscopic, completely transnasal approach to the middle third of the clivus, petrous bone, middle cranial fossa, and infratemporal fossa","volume":"19","author":"Kassam","year":"2005","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2019.03.049_bib239","first-page":"400","article-title":"Endoscopic, endonasal extended transsphenoidal, transplanum transtuberculum approach for resection of suprasellar lesions","volume":"106","author":"Laufer","year":"2007","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/2152-7806.157442","article-title":"The expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: A 2014 perspective","volume":"6","author":"Lobo","year":"2015","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.wneu.2019.03.049_bib241","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000091573","article-title":"Endoscopic endonasal cavernous sinus surgery, with special reference to pituitary adenomas","volume":"34","author":"Frank","year":"2006","journal-title":"Front Horm Res"},{"key":"10.1016\/j.wneu.2019.03.049_bib242","first-page":"825","article-title":"Extended transsphenoidal approach","volume":"102","author":"Laws","year":"2005","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib243","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00701-017-3448-x","article-title":"Endoscopic transorbital route to the petrous apex: a feasibility anatomic study","volume":"160","author":"Di Somma","year":"2018","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2019.03.049_bib244","author":"Di Somma"},{"key":"10.1016\/j.wneu.2019.03.049_bib245","first-page":"1203","article-title":"Endoscopic transorbital superior eyelid approach: anatomical study from a neurosurgical perspective","volume":"129","author":"Di Somma","year":"2018","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib246","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00405-012-2281-3","article-title":"Endoscopic endonasal anatomy of superior orbital fissure and orbital apex regions: critical considerations for clinical applications","volume":"270","author":"Dallan","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.wneu.2019.03.049_bib247","first-page":"622","article-title":"Endoscopic transorbital route to the cavernous sinus through the meningo-orbital band: a descriptive anatomical study","volume":"127","author":"Dallan","year":"2017","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.03.049_bib248","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2466\/pms.1994.78.3c.1385","article-title":"Simultaneous changes in length and direction as a cue for perceived depth","volume":"78","author":"Brigner","year":"1994","journal-title":"Percept Mot Skills"},{"key":"10.1016\/j.wneu.2019.03.049_bib249","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/S0042-6989(00)00178-4","article-title":"Depth cue integration: stereopsis and image blur","volume":"40","author":"Mather","year":"2000","journal-title":"Vision Res"},{"key":"10.1016\/j.wneu.2019.03.049_bib250","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1068\/pmkrog","article-title":"Motion parallax as an independent cue for depth perception: a retrospective","volume":"38","author":"Rogers","year":"2009","journal-title":"Perception"},{"key":"10.1016\/j.wneu.2019.03.049_bib251","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-0028-1104567","article-title":"Three-dimensional neurostereoendoscopy: subjective and objective comparison to 2D","volume":"52","author":"Fraser","year":"2009","journal-title":"Minim Invasive Neurosurg"},{"issue":"5 suppl 2","key":"10.1016\/j.wneu.2019.03.049_bib252","first-page":"288","article-title":"Three-dimensional endoscopic pituitary surgery","volume":"64","author":"Tabaee","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib253","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/alr.20036","article-title":"Comparison of traditional 2-dimensional endoscopic pituitary surgery with new 3-dimensional endoscopic technology: intraoperative and early postoperative factors","volume":"2","author":"Kari","year":"2012","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1 suppl operative","key":"10.1016\/j.wneu.2019.03.049_bib254","first-page":"ons74","article-title":"Evaluation of the 3-dimensional endoscope in transsphenoidal surgery","volume":"73","author":"Barkhoudarian","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.03.049_bib255","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00701-014-2128-3","article-title":"Have 3D endoscopes succeeded in neurosurgery?","volume":"156","author":"Cavallo","year":"2014","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2019.03.049_bib256","doi-asserted-by":"crossref","first-page":"E351","DOI":"10.1002\/hed.23238","article-title":"Combined transoral robotic surgery and endoscopic endonasal approach for the resection of extensive malignancies of the skull base","volume":"35","author":"Carrau","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.wneu.2019.03.049_bib257","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archotol.133.12.1215","article-title":"Robotic skull base surgery: preclinical investigations to human clinical application","volume":"133","author":"O'Malley","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2 suppl","key":"10.1016\/j.wneu.2019.03.049_bib258","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.ijrobp.2007.06.028","article-title":"Robotic anterior and midline skull base surgery: preclinical investigations","volume":"69","author":"O'Malley","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2019.03.049_bib259","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/lary.24034","article-title":"Applications of transoral, transcervical, transnasal, and transpalatal corridors for robotic surgery of the skull base","volume":"123","author":"Ozer","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.wneu.2019.03.049_bib260","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.anorl.2012.03.010","article-title":"Robotic endoscopic sinus and skull base surgery: review of the literature and future prospects","volume":"130","author":"Trevillot","year":"2013","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019306813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019306813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:26:00Z","timestamp":1761812760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875019306813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":260,"alternative-id":["S1878875019306813"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2019.03.049","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary Adenomas: What Are the Key Features? What Are the Current Treatments? Where Is the Future Taking Us?","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2019.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}